Latest News Archive
Please select Category, Year, and then Month to display items
20 June 2023
|
Story Melissa Kilian
|
Photo Supplied
Melissa Kilian is a Lecturer in the Department of Occupational Therapy.
The University of the Free State (UFS) is celebrating Youth Month by showcasing the positive influence of the institution on career development. As part of this initiative, we are sharing the stories of UFS alumni who are now working at the university.
Melissa Kilian, Lecturer in the Department of Occupational Therapy, shares her UFS journey:
Q: Year of graduation from the UFS:
A: 2011 and 2021.
Q: Qualification obtained from the UFS:
A: Baccalaureus and Master of Occupational Therapy.
Q: Date of joining the UFS as a staff member:
A: 1 June 2022 (employed for one year this month).
Q: Initial job title and current job title:
A: Lecturer in Occupational Therapy.
Q: How did the UFS prepare you for the professional world?
A: The UFS provided me with excellent clinical exposure to the diverse profession of occupational therapy. Additionally, the occupational therapy undergraduate course provided many opportunities for promoting self-awareness and self-development and entering the workforce as a graduate willing to explore the dimensions of the profession and what my unique contribution can be.
Q: What are your thoughts on transitioning from a UFS alumnus to a staff member?
A: Since being employed with the UFS, I have a deeper acknowledgement and appreciation for lecturers, as well as a multi-layered understanding of the importance of curriculum development and how this translates into students becoming competent graduates.
Q: Any additional comments about your experience?
A: It’s been quite an experience ...!
UFS researcher explores the future cost of cancer
2017-01-10
Dr Alicia Sherriff, Head the Department of Oncology
at the UFS Faculty of Health Sciences, co-authored
an article in the South African Medical Journal.
Photo: Charl Devenish
Cancer is on an exponential rise globally, and the cost of treatment is a growing international problem. South Africa alone is expected to see a 78% increase in cancer cases. Dr Alicia Sheriff, Head of the Department of Oncology, collaborated on and co-authored a research paper for the South African Medical Journal on the future of oncology treatment in the country, along with doctors from various universities across South Africa. The article, titled "The future cost of cancer: interdisciplinary cost management strategy", looks at the prognosis of cancer management in the country.
Cancer is on the rise
There is a visible growth of the cancer disease in the developing world. Rapidly changing lifestyles, uncontrolled urbanisation, pollution, and population ageing are some dynamics that provide a lethal cocktail of infectious and lifestyle risk factors that leave people at a higher risk of developing cancer.
The simultaneous increase in cancer incidence has increased the cost of treatment exponentially. The cost of cancer treatment is multitiered, making the provision of care for cancer patients a high-risk business. A combination of treatment delays, limited resources, differently skilled personnel, high patient volumes and advanced disease stage on presentation all place a bigger burden on the delivery of optimal cancer care outcomes.
Adoption of new strategies
According to the doctors, innovative thinking to embrace technology, combined with a preventive approach, as well as lowering the cost of treatment drugs should be prioritised. So should the commercialisation of new technologies that will diagnose and treat cancer in its early stages. They also encourage interdisciplinary research funding in South Africa as a way to better understand the demographic and molecular dynamics of cancer in the country, along with retaining more oncologists in the public health sector.
Efficient solutions to curb cancer mortality
The doctors assert there is a need to continue to look for more efficient measures to best treat the disease, and hopefully bring about a change in mortality levels in South Africa.